APR 24, 2018 09:11 PM PDT

New Treatment Option for the Non-Cancerous Form of the Prostate

WRITTEN BY: Nouran Amin

A new therapy known as ‘prostate artery embolization’ or PAE seeks to treat the non-cancerous enlargement of the prostate, or benign prostatic hyperplasia (BPH), which is a common condition seen in older men.

Prostate artery embolization blocks some of the blood supply from reaching the prostate using tiny synthetic beads, ultimately treating troubling tissue. The treatment is non-invasive and may spare men surgery and side-effects including impotence. “Prostate artery embolization gives men with BPH a treatment option that is less invasive than other therapies and allows them to return to their normal lives sooner.”

Having an enlarged prostate is seen in about a third of men over the age of 50, which can make it difficult for them to pass urine. Currently, some drug treatments and surgical interventions can help however, other treatment options should be offered. In fact, roughly 20 research centers in the UK have already placed patients on this treatment has part of a clinical trial.

A consultant interventional radiologist at the University Hospital Southampton, Dr Nigel Hacking, explains that, "It is a particularly good option for men who are not yet ready to undergo more invasive prostate surgery. Maintaining sexual function and fertility is one of its main strengths” says lead author of the PAE study, Joao Martins Pisco, “this minimally invasive treatment is successful in the long term and should always be presented to patients who are exploring options to resolve their BPH.”

The prostate gland is a crucial part of the male reproductive system, and it works to produce the fluid to carry and nurture sperm. With BAE, if left untreated, it may interfere with the bladder function, causing affected men to go use the toilet to pass urine. If BPH is not treated at all it can cause urine infections and/or damage to the bladder and kidneys.

Sources: BBC News, Urology Health

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 13, 2018
Drug Discovery
JUL 13, 2018
Pharmacological Strategy Attempts To Treat Multiple Symptoms of Fragile X
Recent research in a mouse model of fragile X syndrome (FXS), scheduled for publication in Neuropsychopharmacology, shows that a pharmacological strategy c...
JUL 12, 2018
Infographics
JUL 12, 2018
3D Imaging Advantage
Learn about the advantages and the technology behind 3D cellular image acquisition and analysis with this infographic from Molecular Devices....
JUL 24, 2018
Drug Discovery
JUL 24, 2018
Therapeutic Target For Kidney Cancers
Researchers at Lineberger Comprehensive Cancer Center in University of North Carolina revealed a therapeutic target for kidney cancers that share a common ...
JUL 28, 2018
Videos
JUL 28, 2018
23andMe Announces Partnership with Drug Company GSK
The collaboration aims to improve personalized therapeutics....
AUG 21, 2018
Drug Discovery
AUG 21, 2018
Genetic Regulators of Regeneration Bring Hope for Drug Discovery
Portions of DNA that do not seem to have a function are referred to as “junk”. Now, according to a study published in Regenerative Medicine, re...
SEP 11, 2018
Drug Discovery
SEP 11, 2018
Widely-Used Drug Contributed To Skin Cancer
In a research study at the University of Dundee, Queen Mary University of London and the Wellcome Sanger Institute, a drug, by the name of azathioprine, wh...
Loading Comments...